Literature DB >> 2521178

HBsAg carrier infants with serum anti-HBc negativity.

S D Lee1, K J Lo, Y T Tsai, J C Wu, T C Wu.   

Abstract

A total of 128 HBsAg carrier infants born to HBeAg-positive HBsAg carrier mothers were tested for serum HBsAg, HBeAg, hepatitis B virus DNA and anti-HBc. Ninety-three of them had received hepatitis B vaccination. Anti-HBc had been found to be negative in sera of 12 infants who were HBsAg, HBeAg and hepatitis B virus DNA positive during the follow-up period of 3 to 5 years. Liver damage, as measured by serum ALT levels, was found to be normal among the 12 HBsAg carrier infants with serum anti-HBc negativity, whereas 39.7% of the 116 anti-HBc-positive HBsAg carrier infants had abnormal ALT levels during the follow-up period. Anti-HBe and anti-HBs also were not detected in sera of these anti-HBc-negative HBsAg carrier infants. Thus, HBsAg carrier infants with anti-HBc negativity probably result from immune incompetency of the hepatitis B virus antigens.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2521178     DOI: 10.1002/hep.1840090117

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  4 in total

1.  Immune suppression as the etiology of failure to detect anti-HBc antibodies in patients with chronic hepatitis B virus infection.

Authors:  V Avettand-Fenoel; D Thabut; C Katlama; T Poynard; V Thibault
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

Review 2.  New strategies for blood donor screening for hepatitis B virus: nucleic acid testing versus immunoassay methods.

Authors:  Mary C Kuhns; Michael P Busch
Journal:  Mol Diagn Ther       Date:  2006       Impact factor: 4.074

3.  Clinical significance of low or negative titer of antibody to hepatitis B core antigen during the course of chronic hepatitis B virus infection in adolescents.

Authors:  K Matsuura; K Tobe; Y Iwasaki; H Ikeda; K Takahashi; T Tsuji
Journal:  Gastroenterol Jpn       Date:  1993-02

4.  Hepatitis B serological markers and plasma DNA concentrations.

Authors:  Huw Price; David Dunn; Tamale Zachary; Tobias Vudriko; Michael Chirara; Cissy Kityo; Paula Munderi; Moira Spyer; James Hakim; Charles Gilks; Pontiano Kaleebu; Deenan Pillay; Richard Gilson
Journal:  AIDS       Date:  2017-05-15       Impact factor: 4.177

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.